Some people may refer to these as “Viagra for females.” The Food and Drug Administration (FDA) have approved two drugs — flibanserin (Addyi) and bremelanotide (Vyleesi) — to address low ...

Erectile dysfunction (ED) is a common condition, and many people find that it is treatable with Viagra — sometimes called the “little blue pill” — and its generic form, sildenafil.

FY 2024 net sales[1] of USD 10.4 billion, up by 9%[2] in constant currencies (+7% in USD); Q4 net sales of USD 2.7 billion, up by 9% in constant currencies (+7% in USD) Strong sales performances in ...

Herbal Viagra: What Is It & Is It Safe? This article was reviewed by Kelly Brown, MD, MBA. Getting herbal Viagra is easy — you can usually find these cleverly packaged and over-hyped supplements ...

Sexyland is supplying tablets and gels advertised to prolong sex for males, with effects similar to Viagra, in at least four of its stores in Victoria — in Geelong, Hallam, Moorabbin and Springvale.

Erectile dysfunction meds, like Viagra and Cialis, can help you get and keep an erection. However, each has different side effects, dosage schedules, and other factors. Here, we look at how they ...

According to Novartis’ annual report, the Sandoz Family Foundation recently held a 4.1% stake in the pharmaceutical company. According to the news agency Reuters, the foundation is now offering ...

(Bloomberg) -- Novartis AG’s Sandoz family is poised to sell a roughly 1.2% stake in the Swiss pharmaceutical group. The Sandoz Family Foundation, through the vehicle Emasan AG, is offering 26.5 ...

ZURICH (Reuters) - The investment vehicle of the Sandoz family will get 2.6 billion Swiss francs ($2.90 billion) from selling a chunk of Swiss pharma giant Novartis, the bookrunner on the deal ...

ZURICH, Feb 26 (Reuters) - The investment vehicle of the Sandoz family will get 2.6 billion Swiss francs ($2.90 billion) from selling a chunk of Swiss pharma giant Novartis (NOVN.S), opens new tab ...

Sandoz, the global leader in generic and biosimilar medicines, announces the launch of Pyzchiva (ustekinumab-ttwe) in the US. From February 24, the medicine is commercially available to patients ...

ZURICH, Feb 25 (Reuters) - Emasan AG, an arm of the Sandoz Family Foundation, has launched a public offering of some 26.5 million shares in Swiss pharmaceutical firm Novartis to raise up to $3 ...